Foley Partner George Best and Associate Shaun Snader authored an article titled “Accelerated FDA Review: Risks to Patent Term” in the July/August 2009 issue of Update Magazine.
Reprinted with permission from FDLI.
Related Insights
February 10, 2026
Health Care Law Today
PBM Reform Cheat Sheet: Chart Comparing the Recent Rules for Group Plans
Key Takeaways: Within a one-week period, there were two actions at the federal level to increase pharmacy benefits manager (PBM)…
February 10, 2026
Foley Viewpoints
PBM Reform Cheat Sheet: Chart Comparing the Recent Rules for Group Plans
Key Takeaways: Within a one-week period, there were two actions at the federal level to increase pharmacy benefits manager (PBM)…
March 26, 2026
Events
Exploring the Subtleties and Safe Zones of Off-Label Communications — Part 2
Foley partner Kyle Faget, co-chair of the Medical Devices & Equipment Area of Focus within the firm’s Health Care & Life Sciences Sector, is speaking on the panel “Exploring the Subtleties and Safe Zones of Off-Label Communications — Part 2” during the American Conference Institute’s FDA Boot Camp program on Thursday, March 26.